Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Vitale

Showing results (281-290 of 288) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 288 results.
JHEP Reports : Innovation in Hepatology|July 4, 2024
Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndromeGiammauro Berardi, Alessandro Cucchetti, Carlo Sposito, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 12, 2025
Laparoscopic versus open resection for hepatocellular carcinoma according to the procedure's complexity: real-world weighted data from a national registerSimone Famularo, Flavio Milana, Francesco Ardito, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 7, 2023
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant ConsortiumBenjamin V Tran, Dimitrios Moris, Daniela Markovic, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 25, 2023
Survival benefit of second line therapies for recurrent hepatocellular carcinoma: repeated hepatectomy, thermoablation and second-line transplant referral in a real life national scenarioSimone Famularo, Umberto Cillo, Andrea Lauterio, et al.
JHEP Reports : Innovation in Hepatology|September 16, 2024
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry studyAlessandro Vitale, Silvia Trapani, Francesco Paolo Russo, et al.
JAMA Surgery|May 21, 2024
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular CarcinomaAlessandro Vitale, Pierluigi Romano, Umberto Cillo, et al.
JHEP Reports : Innovation in Hepatology|July 21, 2025
Minimally invasive hepatectomy <i>vs.</i> thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparisonFelice Giuliante, Simone Famularo, Sara Grasselli, et al.
Liver Cancer|October 9, 2025
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse StudyAlessandro Vitale, Jung Sun Kim, Giuseppe Cabibbo, et al.
Pageof 29

Showing results (281-290 of 288) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 288 results.
JHEP Reports : Innovation in Hepatology|July 4, 2024
Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndromeGiammauro Berardi, Alessandro Cucchetti, Carlo Sposito, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 12, 2025
Laparoscopic versus open resection for hepatocellular carcinoma according to the procedure's complexity: real-world weighted data from a national registerSimone Famularo, Flavio Milana, Francesco Ardito, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 7, 2023
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant ConsortiumBenjamin V Tran, Dimitrios Moris, Daniela Markovic, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 25, 2023
Survival benefit of second line therapies for recurrent hepatocellular carcinoma: repeated hepatectomy, thermoablation and second-line transplant referral in a real life national scenarioSimone Famularo, Umberto Cillo, Andrea Lauterio, et al.
JHEP Reports : Innovation in Hepatology|September 16, 2024
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry studyAlessandro Vitale, Silvia Trapani, Francesco Paolo Russo, et al.
JAMA Surgery|May 21, 2024
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular CarcinomaAlessandro Vitale, Pierluigi Romano, Umberto Cillo, et al.
JHEP Reports : Innovation in Hepatology|July 21, 2025
Minimally invasive hepatectomy <i>vs.</i> thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparisonFelice Giuliante, Simone Famularo, Sara Grasselli, et al.
Liver Cancer|October 9, 2025
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse StudyAlessandro Vitale, Jung Sun Kim, Giuseppe Cabibbo, et al.
Pageof 29